Dexamethasone Unknown Status Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0050586 (Dexamethasone)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02027220Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple MyelomaTreatment